Farther Finance Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Farther Finance Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-135	Closed	-$3.19K	–	3769
2023 Q4	$3.19K	Buy	+135	New	+$2.4K	﹤0.01%	2203

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's CBAY Position: Q1 2024 in Review

Farther Finance Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 135 shares — an estimated $3.19K sold.

Farther Finance Advisors first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $3.19K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Farther Finance Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Farther Finance Advisors sold 135 Cymabay Therapeutics shares in Q1 2024, an estimated $3.19K.
Farther Finance Advisors first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Farther Finance Advisors's Cymabay Therapeutics position peaked at $3.19K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Farther Finance Advisors's 13F filing for Q1 2024, filed 14 May 2024.